0
     

Report Added
Report already added
Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) - Global Forecast to 2027

Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) - Global Forecast to 2027

The pharmaceutical excipients market is projected to reach USD 11.5 Billion by 2027 from USD 8.6 Billion in 2022, at a CAGR of 5.9% during the forecast period. The growth can be attributed to the expanding pharmaceutical industry which has fueled the drug production thereby increasing consumption rate for excipients. Additionally, factors like functional excipients development and upsurge in generics market is also likely to propel market growth.

“The fillers & diluents functionality accounted for the largest share of the market in 2021”

The fillers and diluents market is expected to grow due to the rising use of fillers and diluents in developing and producing solid oral drugs. From the manufacturer’s perspective, fillers and diluents offer stability and ease in preparation, packaging, shipping, and dispensing; for patients, they improve the taste of the formulation and provide ease of administration and handling (of the drug).

“The oral formulations accounted for the major share of the pharmaceutical excipients market in 2021”

The rapidly growing biopharmaceutical industry and increased generics production are the key growth drivers for this segment growth. Furthermore, the oral route of administration is the most common and traditional route for drug delivery. This has also boosted the segment market growth.

Ashland Global Holdings, Inc (US), International Flavors & Fragrances, Inc. (US), BASF SE (Germany), Evonik Industries AG (Germany), Roquette Frères (France), Associated British Foods plc (UK), Archer Daniels Midland Company (US), Lubrizol Corporation (US), Innophos Holdings (US), Kerry Group plc (Ireland), Wacker Chemie AG (Germany), Air Liquide (France), Dow Chemicals (US), Colorcon (US), DMV-Fonterra Excipients (Germany), JRS Pharma GmbH (Germany), Meggle GmbH & Co Kg (Germany), Finar Limited (India), Fuji Chemical Industries Co., Ltd (Japan), Merck KGaA (Germany), Captisol (US), Ideal Cures Pvt. Ltd (India), Corel Pharma Chem (India), Biogrund GmbH (Germany), Nitika Pharmaceutical Specialties Pvt. Ltd (India), are some of the major players operating in the market.

“Asia Pacific: The fastest-growing region in the pharmaceutical excipients market”

The market is segmented into North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA). The Asia Pacific market is expected to register the highest CAGR during the forecast period. ). The Asia Pacific market is expected to register the highest CAGR during the forecast period. Some of the major factors contributing to the growth of the Asia Pacific market are low-cost manufacturing advantage, increasing per capita income, and low regulatory stringency that support the growth of the pharmaceutical excipients market in the region.

The primary interviews conducted for this report can be categorized as follows:
•By Respondent: Supply Side- 80% and Demand Side - 20%
•By Designation: Managers- 45%, CXOs and Director level - 30%, and Executives - 25%
•By Region: North America -20%, Europe -10%, Asia-Pacific -55%, RoW -15%

List of Companies Profiled in the Report:
•Ashland Global Holdings, Inc (US)
• International Flavors & Fragrances, Inc. (US)
• BASF SE (Germany)
• Evonik Industries AG (Germany)
• Roquette Frères (France)
• Associated British Foods plc (UK)
• Archer Daniels Midland Company (US)
• Lubrizol Corporation (US)
• Innophos Holdings (US)
•Kerry Group plc (Ireland)
• Wacker Chemie AG (Germany)
• Air Liquide (France)
• Dow Chemicals (US)
• Colorcon (US)
• DMV-Fonterra Excipients (Germany)
• JRS Pharma GmbH (Germany)
• Meggle GmbH & Co Kg (Germany)
•Finar Limited (India)
• Fuji Chemical Industries Co., Ltd (Japan)
• Merck KGaA (Germany), Captisol (US)
• Ideal Cures Pvt. Ltd (India)
• Corel Pharma Chem (India)
• Biogrund GmbH (Germany)
• Nitika Pharmaceutical Specialties Pvt. Ltd (India)

Research Coverage:
This report provides a detailed picture of the pharmaceutical excipients market. It aims at estimating the size and future growth potential of the market across different segments such as the product, functionality, formulation and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical excipients market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, trends, and opportunities.
Table of Contents

1INTRODUCTION57
1.1OBJECTIVES OF THE STUDY57
1.2MARKET DEFINITION57
1.2.1INCLUSIONS AND EXCLUSIONS57
1.3MARKET SCOPE58
1.3.1MARKETS COVERED58
FIGURE 1PHARMACEUTICAL EXCIPIENTS MARKET58
1.3.2YEARS CONSIDERED FOR THE STUDY59
1.4CURRENCY59
1.5LIMITATIONS59
1.6STAKEHOLDERS60
1.7SUMMARY OF CHANGES60
2RESEARCH METHODOLOGY61
2.1RESEARCH DATA61
FIGURE 2RESEARCH DESIGN61
2.1.1SECONDARY DATA62
2.1.2PRIMARY DATA62
FIGURE 3BREAKDOWN OF PRIMARIES BY RESPONDENT, DESIGNATION, AND REGION: PHARMACEUTICAL EXCIPIENTS MARKET63
2.2MARKET ESTIMATION METHODOLOGY64
FIGURE 4PHARMACEUTICAL EXCIPIENTS MARKET SIZE ESTIMATION
(SUPPLY-SIDE ANALYSIS), 202164
FIGURE 5MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 202164
2.2.1INSIGHTS FROM PRIMARY EXPERTS65
FIGURE 6MARKET SIZE VALIDATION FROM PRIMARY SOURCES65
2.3MARKET GROWTH RATE PROJECTIONS66
FIGURE 7PHARMACEUTICAL EXCIPIENTS MARKET (SUPPLY SIDE): CAGR PROJECTIONS67
FIGURE 8PHARMACEUTICAL EXCIPIENTS MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS67
2.3.1DATA TRIANGULATION68
FIGURE 9DATA TRIANGULATION METHODOLOGY68
2.4RESEARCH ASSUMPTIONS68
2.4.1COVID-19 ASSUMPTIONS69
2.5RISK ANALYSIS69

3EXECUTIVE SUMMARY70
FIGURE 10PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2022 VS. 2027 (USD MILLION)70
FIGURE 11PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2022 VS. 2027 (USD MILLION)71
FIGURE 12PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2022 VS. 2027 (USD MILLION)71
FIGURE 13GEOGRAPHICAL SNAPSHOT OF THE PHARMACEUTICAL EXCIPIENTS MARKET72
4PREMIUM INSIGHTS73
4.1PHARMACEUTICAL EXCIPIENTS: MARKET OVERVIEW73
FIGURE 14GROWING PHARMACEUTICALS INDUSTRY, COUPLED WITH ADVANCEMENTS IN FUNCTIONAL EXCIPIENTS, ARE KEY FACTORS DRIVING MARKET GROWTH73
4.2ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY FORMULATION AND COUNTRY (2020)74
FIGURE 15ORAL FORMULATIONS ACCOUNTED FOR THE LARGEST SHARE OF
THE ASIA PACIFIC MARKET IN 202174
4.3PHARMACEUTICALS EXCIPIENTS MARKET SHARE, BY PRODUCT, 2022 VS. 202774
FIGURE 16ORGANIC CHEMICALS SEGMENT WILL CONTINUE TO DOMINATE
THE MARKET IN 202774
4.4PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY FORMULATION, 202275
FIGURE 17ORAL FORMULATIONS SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 202275
4.5PHARMACEUTICAL EXCIPIENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES75
FIGURE 18ASIA PACIFIC COUNTRIES TO SHOW THE HIGHEST GROWTH DURING THE FORECAST PERIOD75
5MARKET OVERVIEW76
5.1INTRODUCTION76
5.2MARKET DYNAMICS76
FIGURE 19PHARMACEUTICAL EXCIPIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES76
TABLE 1PHARMACEUTICAL EXCIPIENTS MARKET: IMPACT ANALYSIS77
5.2.1DRIVERS77
5.2.1.1Growth of the pharmaceuticals market backed by functional excipients77
FIGURE 20GLOBAL PHARMACEUTICAL DRUG SALES (2008–2022)78
5.2.1.2Surge in the generics market78
TABLE 2DRUG PATENT EXPIRY, BY YEAR79
5.2.1.3Increasing uptake of biopharmaceuticals80
5.2.1.4Rising adoption of orphan drugs80
FIGURE 21INCREASING PENETRATION OF ORPHAN DRUGS (2010–2024)80
FIGURE 22RISING NUMBER OF ORPHAN INDICATIONS APPROVED IN THE US81
5.2.2RESTRAINTS81
5.2.2.1Cost and time-intensive drug development process81
5.2.2.2Increasing regulatory stringency82
5.2.3OPPORTUNITIES83
5.2.3.1Multifunctional excipients83
TABLE 3MULTIFUNCTIONAL EXCIPIENTS83
5.2.3.2Shifting focus of pharmaceutical manufacturing to emerging countries84
5.2.3.3Growth in the biosimilars market85
5.2.4CHALLENGES85
5.2.4.1Safety and quality concerns85
5.2.4.2Changing trade policies86
5.2.5INDUSTRY TRENDS86
5.2.5.1Rising demand for co-processed excipients86
TABLE 4MARKETED CO-PROCESSED EXCIPIENTS87
5.2.5.2Improving excipient capabilities using nanotechnology88
5.2.5.3Increasing use of direct compression in oral dosage formulations88
5.2.5.4Pharmaceutical excipients influencing the cost of production89
5.3RANGES/SCENARIO90
FIGURE 23SPECTRUM OF SCENARIOS BASED ON THE IMPACT OF UNCERTAINTIES ON THE GROWTH OF THE PHARMACEUTICAL EXCIPIENTS MARKET90
5.4IMPACT OF COVID-19 ON THE PHARMACEUTICAL EXCIPIENTS MARKET90
FIGURE 24INCREASE IN REVENUE, BY QUARTER91
FIGURE 25COVID-19 IMPACT ON SECTIONS OF THE PHARMACEUTICAL INDUSTRY91
FIGURE 26PHARMACEUTICAL EXCIPIENTS MARKET SCENARIO WITH AND WITHOUT COVID-19 IMPACT, 2019-202192
5.5TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS93
FIGURE 27REVENUE SHIFT AND NEW POCKETS FOR PHARMACEUTICAL EXCIPIENTS PROVIDERS93
5.6TRADE DATA93
5.6.1SUCROSE93
5.6.2PREPARED BINDERS FOR MOLDS/CORES, CHEMICAL PRODUCTS, AND PREPARATION FOR CHEMICAL INDUSTRIES94
5.6.3MANNITOL (ACYCLIC ALCOHOLS & THEIR DERIVATIVES)94
5.6.4CELLULOSE95
5.7INDICATIVE PRICING MODEL ANALYSIS95
5.7.1US95
5.7.2CHINA96
5.7.3INDIA96
5.8VALUE CHAIN ANALYSIS96
FIGURE 28VALUE CHAIN ANALYSIS OF THE PHARMACEUTICAL EXCIPIENTS MARKET97
5.9SUPPLY CHAIN ANALYSIS97
FIGURE 29PHARMACEUTICAL EXCIPIENTS MARKET: SUPPLY CHAIN ANALYSIS98
5.10ECOSYSTEM ANALYSIS99
FIGURE 30ECOSYSTEM ANALYSIS: PHARMACEUTICAL EXCIPIENTS MARKET99
TABLE 5SUPPLY CHAIN ECOSYSTEM99
5.11PATENT ANALYSIS101
FIGURE 31PATENT APPLICATIONS FOR THE PHARMACEUTICAL EXCIPIENTS MARKET, JANUARY 2012–MAY 2022101
TABLE 6INDICATIVE LIST OF PATENTS IN THE PHARMACEUTICAL EXCIPIENTS MARKET102
5.12KEY CONFERENCES AND EVENTS, 2022–2023103
TABLE 7CONFERENCES, 2022–2023103
5.13REGULATORY ANALYSIS103
5.13.1NORTH AMERICA104
5.13.1.1US104
5.13.1.2Canada105
5.13.2EUROPE105
5.13.3ASIA PACIFIC106
5.13.3.1Japan106
5.13.3.2China107
5.13.3.3India107
5.14PORTER’S FIVE FORCES ANALYSIS108
TABLE 8PHARMACEUTICAL EXCIPIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS108
5.14.1THREAT OF NEW ENTRANTS108
5.14.2THREAT OF SUBSTITUTES108
5.14.3BARGAINING POWER OF BUYERS108
5.14.4BARGAINING POWER OF SUPPLIERS109
5.14.5DEGREE OF COMPETITION109
5.15KEY STAKEHOLDERS AND BUYING CRITERIA109
5.15.1KEY STAKEHOLDERS IN COMPANIES AND THEIR INFLUENCE ON THE BUYING PROCESS109
FIGURE 32INFLUENCE OF COMPANY STAKEHOLDERS IN THE BUYING PROCESS OF PHARMACEUTICAL EXCIPIENTS PRODUCTS109
5.15.2KEY BUYING CRITERIA FOR PHARMACEUTICAL EXCIPIENT PRODUCTS AMONG END USERS109
FIGURE 33KEY BUYING CRITERIA FOR END USERS109
6PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT110
6.1INTRODUCTION111
TABLE 9PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)111
6.2ORGANIC CHEMICALS111
TABLE 10PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)111
TABLE 11PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,
BY REGION, 2020–2027 (USD MILLION)112
TABLE 12NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION)112
TABLE 13EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION)112
TABLE 14ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION)113
6.2.1OLEOCHEMICALS113
TABLE 15OLEOCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)113
TABLE 16OLEOCHEMICALS MARKET, BY REGION, 2020–2027 (USD MILLION)114
TABLE 17NORTH AMERICA: OLEOCHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)114
TABLE 18EUROPE: OLEOCHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)114
TABLE 19ASIA PACIFIC: OLEOCHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)115
6.2.1.1Fatty alcohols115
6.2.1.1.1Fatty alcohols are widely used as nonionic surfactants due to their amphipathic nature—a major driver for market growth115
TABLE 20FATTY ALCOHOLS MARKET, BY REGION, 2020–2027 (USD MILLION)115
TABLE 21NORTH AMERICA: FATTY ALCOHOLS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)116
TABLE 22EUROPE: FATTY ALCOHOLS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)116
TABLE 23ASIA PACIFIC: FATTY ALCOHOLS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)116
6.2.1.2Mineral stearates117
6.2.1.2.1Wide use of magnesium stearates as excipients in nutraceutical and pharmaceutical formulations to drive market growth117
TABLE 24METAL STEARATES MARKET, BY REGION, 2020–2027 (USD MILLION)117
TABLE 25NORTH AMERICA: METAL STEARATES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)117
TABLE 26EUROPE: METAL STEARATES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)118
TABLE 27ASIA PACIFIC: METAL STEARATES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)118
6.2.1.3Glycerin118
6.2.1.3.1Extensive applications of glycerin to drive market growth118
TABLE 28GLYCERIN MARKET, BY REGION, 2020–2027 (USD MILLION)119
TABLE 29NORTH AMERICA: GLYCERIN MARKET, BY COUNTRY,
2020–2027 (USD MILLION)119
TABLE 30EUROPE: GLYCERIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)119
TABLE 31ASIA PACIFIC: GLYCERIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)120
6.2.1.4Other oleochemicals120
TABLE 32OTHER OLEOCHEMICALS MARKET, BY REGION, 2020–2027 (USD MILLION)120
TABLE 33NORTH AMERICA: OTHER OLEOCHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)120
TABLE 34EUROPE: OTHER OLEOCHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)121
TABLE 35ASIA PACIFIC: OTHER OLEOCHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)121
6.2.2CARBOHYDRATES121
TABLE 36CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)122
TABLE 37CARBOHYDRATES MARKET, BY REGION, 2020–2027 (USD MILLION)122
TABLE 38NORTH AMERICA: CARBOHYDRATES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)122
TABLE 39EUROPE: CARBOHYDRATES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)123
TABLE 40ASIA PACIFIC: CARBOHYDRATES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)123
6.2.2.1Sugars123
TABLE 41SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)124
TABLE 42SUGARS MARKET, BY REGION, 2020–2027 (USD MILLION)124
TABLE 43NORTH AMERICA: SUGARS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)124
TABLE 44EUROPE: SUGARS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)125
TABLE 45ASIA PACIFIC: SUGARS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)125
6.2.2.1.1Actual sugars125
6.2.2.1.1.1Growing use of actual sugars in pediatric formulations drives the market growth125
TABLE 46ACTUAL SUGARS MARKET, BY REGION, 2020–2027 (USD MILLION)126
TABLE 47NORTH AMERICA: ACTUAL SUGARS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)126
TABLE 48EUROPE: ACTUAL SUGARS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)127
TABLE 49ASIA PACIFIC: ACTUAL SUGARS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)127
6.2.2.1.2Sugar alcohols127
6.2.2.1.2.1Mannitol to show the highest growth in the market for sugar alcohols127
TABLE 50SUGAR ALCOHOLS MARKET, BY REGION, 2020–2027 (USD MILLION)128
TABLE 51NORTH AMERICA: SUGAR ALCOHOLS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)128
TABLE 52EUROPE: SUGAR ALCOHOLS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)129
TABLE 53ASIA PACIFIC: SUGAR ALCOHOLS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)129
6.2.2.1.3Artificial sweeteners129
6.2.2.1.3.1Aspartame is the most used artificial sweetener129
TABLE 54ARTIFICIAL SWEETENERS MARKET, BY REGION, 2020–2027 (USD MILLION)130
TABLE 55NORTH AMERICA: ARTIFICIAL SWEETENERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)130
TABLE 56EUROPE: ARTIFICIAL SWEETENERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)130
TABLE 57ASIA PACIFIC: ARTIFICIAL SWEETENERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)131
6.2.2.2Cellulose131
TABLE 58CELLULOSE MARKET BY TYPE, 2020–2027 (USD MILLION)131
TABLE 59CELLULOSE MARKET BY REGION, 2020–2027 (USD MILLION)132
TABLE 60NORTH AMERICA: CELLULOSE MARKET BY COUNTRY,
2020–2027 (USD MILLION)132
TABLE 61EUROPE: CELLULOSE MARKET BY COUNTRY, 2020–2027 (USD MILLION)132
TABLE 62ASIA PACIFIC: CELLULOSE MARKET BY COUNTRY,
2020–2027 (USD MILLION)133
6.2.2.2.1Microcrystalline cellulose133
6.2.2.2.1.1Microcrystalline cellulose is the most widely used excipient in the direct compression method for tablets133
TABLE 63MICROCRYSTALLINE CELLULOSE MARKET, BY REGION,
2020–2027 (USD MILLION)133
TABLE 64NORTH AMERICA: MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)134
TABLE 65EUROPE: MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY,
2020–2027 (USD MILLION)134
TABLE 66ASIA PACIFIC: MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)134
6.2.2.2.2Cellulose ethers135
6.2.2.2.2.1Cellulose ethers are effective even at a lower concentration135
TABLE 67CELLULOSE ETHERS MARKET, BY REGION, 2020–2027 (USD MILLION)135
TABLE 68NORTH AMERICA: CELLULOSE ETHERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)135
TABLE 69EUROPE: CELLULOSE ETHERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)136
TABLE 70ASIA PACIFIC: CELLULOSE ETHERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)136
6.2.2.2.3CMC & croscarmellose sodium136
6.2.2.2.3.1Multiple advantages of CMC and croscarmellose sodium make them the most widely used suspending agents in injectable preparations136
TABLE 71CMC & CROSCARMELLOSE SODIUM MARKET, BY REGION,
2020–2027 (USD MILLION)137
TABLE 72NORTH AMERICA: CMC & CROSCARMELLOSE SODIUM MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)137
TABLE 73EUROPE: CMC & CROSCARMELLOSE SODIUM MARKET, BY COUNTRY,
2020–2027 (USD MILLION)137
TABLE 74ASIA PACIFIC: CMC & CROSCARMELLOSE SODIUM MARKET, BY COUNTRY, 2020–2027 (USD MILLION)138
6.2.2.2.4Cellulose esters138
6.2.2.2.4.1Cellulose esters enable the delivery of drugs in cellular membranes and the intracellular matrix138
TABLE 75CELLULOSE ESTERS MARKET, BY REGION, 2020–2027 (USD MILLION)138
TABLE 76NORTH AMERICA: CELLULOSE ESTERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)139
TABLE 77EUROPE: CELLULOSE ESTERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)139
TABLE 78ASIA PACIFIC: CELLULOSE ESTERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)139
6.2.2.3Starch140
TABLE 79STARCH MARKET, BY TYPE, 2020–2027 (USD MILLION)140
TABLE 80STARCH MARKET, BY REGION, 2020–2027 (USD MILLION)140
TABLE 81NORTH AMERICA: STARCH MARKET, BY COUNTRY,
2020–2027 (USD MILLION)140
TABLE 82EUROPE: STARCH MARKET, BY COUNTRY, 2020–2027 (USD MILLION)141
TABLE 83ASIA PACIFIC: STARCH MARKET, BY COUNTRY, 2020–2027 (USD MILLION)141
6.2.2.3.1Modified starch141
6.2.2.3.1.1Modified starch is widely used in sustained-release tablets due to its cold-water swelling and gel barrier formation capabilities141
TABLE 84MODIFIED STARCH MARKET, BY REGION, 2020–2027 (USD MILLION)142
TABLE 85NORTH AMERICA: MODIFIED STARCH MARKET, BY COUNTRY,
2020–2027 (USD MILLION)142
TABLE 86EUROPE: MODIFIED STARCH MARKET, BY COUNTRY,
2020–2027 (USD MILLION)142
TABLE 87ASIA PACIFIC: MODIFIED STARCH MARKET, BY COUNTRY,
2020–2027 (USD MILLION)143
6.2.2.3.2Dried starch143
6.2.2.3.2.1Dried starch is a strong binding and coating agent143
TABLE 88DRIED STARCH MARKET, BY REGION, 2020–2027 (USD MILLION)143
TABLE 89NORTH AMERICA: DRIED STARCH MARKET, BY COUNTRY,
2020–2027 (USD MILLION)143
TABLE 90EUROPE: DRIED STARCH MARKET, BY COUNTRY, 2020–2027 (USD MILLION)144
TABLE 91ASIA PACIFIC: DRIED STARCH MARKET, BY COUNTRY,
2020–2027 (USD MILLION)144
6.2.2.3.3Converted starch144
6.2.2.3.3.1Converted starch is used as a molecular encapsulation agent and offers enhanced solubility and stability for drugs144
TABLE 92CONVERTED STARCH MARKET, BY REGION, 2020–2027 (USD MILLION)145
TABLE 93NORTH AMERICA: CONVERTED STARCH MARKET, BY COUNTRY,
2020–2027 (USD MILLION)145
TABLE 94EUROPE: CONVERTED STARCH MARKET, BY COUNTRY,
2020–2027 (USD MILLION)145
TABLE 95ASIA PACIFIC: CONVERTED STARCH MARKET, BY COUNTRY,
2020–2027 (USD MILLION)146
6.2.3PETROCHEMICALS146
TABLE 96PETROCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)146
TABLE 97PETROCHEMICALS MARKET, BY REGION, 2020–2027 (USD MILLION)147
TABLE 98NORTH AMERICA: PETROCHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)147
TABLE 99EUROPE: PETROCHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)147
TABLE 100ASIA PACIFIC: PETROCHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)148
6.2.3.1Glycols148
6.2.3.1.1The availability of highly purified polyethylene glycol to enhance stability has driven the demand148
TABLE 101GLYCOLS MARKET, BY REGION, 2020–2027 (USD MILLION)149
TABLE 102NORTH AMERICA: GLYCOLS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)149
TABLE 103EUROPE: GLYCOLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)149
TABLE 104ASIA PACIFIC: GLYCOLS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)150
6.2.3.2Povidones150
6.2.3.2.1Rising demand for fast-dissolving tablets is expected to propel the growth of this segment150
TABLE 105POVIDONES MARKET, BY REGION, 2020–2027 (USD MILLION)150
TABLE 106NORTH AMERICA: POVIDONES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)151
TABLE 107EUROPE: POVIDONES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)151
TABLE 108ASIA PACIFIC: POVIDONES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)151
6.2.3.3Mineral hydrocarbons152
6.2.3.3.1Growing preference for topical formulations in pain management has supported the demand for mineral hydrocarbons152
TABLE 109MINERAL HYDROCARBONS MARKET, BY REGION,
2020–2027 (USD MILLION)152
TABLE 110NORTH AMERICA: MINERAL HYDROCARBONS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)153
TABLE 111EUROPE: MINERAL HYDROCARBONS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)153
TABLE 112ASIA PACIFIC: MINERAL HYDROCARBONS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)153
6.2.3.4Acrylic polymers154
6.2.3.4.1Wide use of acrylic polymers in controlled-release drug formulations to drive market growth154
TABLE 113ACRYLIC POLYMERS MARKET, BY REGION, 2020–2027 (USD MILLION)154
TABLE 114NORTH AMERICA: ACRYLIC POLYMERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)154
TABLE 115EUROPE: ACRYLIC POLYMERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)155
TABLE 116ASIA PACIFIC: ACRYLIC POLYMERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)155
6.2.3.5Other petrochemical excipients155
TABLE 117OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY REGION,
2020–2027 (USD MILLION)156
TABLE 118NORTH AMERICA: OTHER PETROCHEMICAL EXCIPIENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)156
TABLE 119EUROPE: OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)156
TABLE 120ASIA PACIFIC: OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)157
6.2.4PROTEINS157
6.2.4.1Growing applications of proteins as carriers for microparticles and nanoparticles to drive market growth157
TABLE 121PROTEINS MARKET, BY REGION, 2020–2027 (USD MILLION)157
TABLE 122NORTH AMERICA: PROTEINS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)158
TABLE 123EUROPE: PROTEINS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)158
TABLE 124ASIA PACIFIC: PROTEINS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)158
6.2.5OTHER ORGANIC CHEMICALS159
TABLE 125OTHER ORGANIC CHEMICALS MARKET, BY REGION,
2020–2027 (USD MILLION)159
TABLE 126NORTH AMERICA: OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)159
TABLE 127EUROPE: OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)160
TABLE 128ASIA PACIFIC: OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)160
6.3INORGANIC CHEMICALS160
TABLE 129PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,
BY TYPE, 2020–2027 (USD MILLION)161
TABLE 130PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,
BY REGION, 2020–2027 (USD MILLION)161
TABLE 131NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION)161
TABLE 132EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION)162
TABLE 133ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION)162
6.3.1CALCIUM PHOSPHATE162
6.3.1.1Chemical purity and low incompatibility with drugs aid their high usage in the pharmaceutical industry162
TABLE 134CALCIUM PHOSPHATE MARKET, BY REGION, 2020–2027 (USD MILLION)163
TABLE 135NORTH AMERICA: CALCIUM PHOSPHATE MARKET, BY COUNTRY,
2020–2027 (USD MILLION)163
TABLE 136EUROPE: CALCIUM PHOSPHATE MARKET, BY COUNTRY,
2020–2027 (USD MILLION)163
TABLE 137ASIA PACIFIC: CALCIUM PHOSPHATE MARKET, BY COUNTRY,
2020–2027 (USD MILLION)164
6.3.2METAL OXIDES164
6.3.2.1Availability of silicon oxides in the hydrophobic, hydrophilic, and granulated forms to aid market growth164
TABLE 138METAL OXIDES MARKET, BY REGION, 2020–2027 (USD MILLION)164
TABLE 139NORTH AMERICA: METAL OXIDES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)165
TABLE 140EUROPE: METAL OXIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)165
TABLE 141ASIA PACIFIC: METAL OXIDES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)165
6.3.3HALITES166
6.3.3.1Increased utilization of halites in vaccines and controlled-release formulations is driving their demand in the market166
TABLE 142HALITES MARKET, BY REGION, 2020–2027 (USD MILLION)166
TABLE 143NORTH AMERICA: HALITES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)166
TABLE 144EUROPE: HALITES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)167
TABLE 145ASIA PACIFIC: HALITES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)167
6.3.4CALCIUM CARBONATE167
6.3.4.1Properties such as short disintegration time and excellent mechanical strength for oral dosage formulations to drive the market167
TABLE 146CALCIUM CARBONATE MARKET, BY REGION, 2020–2027 (USD MILLION)168
TABLE 147NORTH AMERICA: CALCIUM CARBONATE MARKET, BY COUNTRY,
2020–2027 (USD MILLION)168
TABLE 148EUROPE: CALCIUM CARBONATE MARKET, BY COUNTRY,
2020–2027 (USD MILLION)168
TABLE 149ASIA PACIFIC: CALCIUM CARBONATE MARKET, BY COUNTRY,
2020–2027 (USD MILLION)169
6.3.5CALCIUM SULFATE169
6.3.5.1Calcium sulfate is a cost-effective, quality-enhancing diluent for solid dosage forms169
TABLE 150CALCIUM SULFATE MARKET, BY REGION, 2020–2027 (USD MILLION)169
TABLE 151NORTH AMERICA: CALCIUM SULFATE MARKET, BY COUNTRY,
2020–2027 (USD MILLION)169
TABLE 152EUROPE: CALCIUM SULFATE MARKET, BY COUNTRY,
2020–2027 (USD MILLION)170
TABLE 153ASIA PACIFIC: CALCIUM SULFATE MARKET, BY COUNTRY,
2020–2027 (USD MILLION)170
6.3.6OTHER INORGANIC CHEMICALS170
TABLE 154OTHER INORGANIC CHEMICALS MARKET, BY REGION,
2020–2027 (USD MILLION)171
TABLE 155NORTH AMERICA: OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)171
TABLE 156EUROPE: OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)171
TABLE 157ASIA PACIFIC: OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)172
6.4OTHER CHEMICALS172
TABLE 158PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS,
BY REGION, 2020–2027 (USD MILLION)172
TABLE 159NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION)173
TABLE 160EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION)173
TABLE 161ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION)173
7PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY174
7.1INTRODUCTION175
TABLE 162PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2027 (USD MILLION)175
7.2FILLERS & DILUENTS175
7.2.1DILUENTS OFFER PROPERTIES SUCH AS IMPROVED COHESION, DIRECT COMPRESSION, AND FLOW TO THE FINAL DOSE IN TABLETS175
TABLE 163PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS,
BY REGION, 2020–2027 (USD MILLION)176
TABLE 164NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY COUNTRY, 2020–2027 (USD MILLION)176
TABLE 165EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY COUNTRY, 2020–2027 (USD MILLION)177
TABLE 166ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY COUNTRY, 2020–2027 (USD MILLION)177
7.3SUSPENDING & VISCOSITY AGENTS177
7.3.1SUSPENSIONS OFFER ADVANTAGES SUCH AS DRUG STABILITY AND TASTE MASKING177
TABLE 167PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY REGION, 2020–2027 (USD MILLION)178
TABLE 168NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)178
TABLE 169EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)179
TABLE 170ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)179
7.4COATING AGENTS179
7.4.1INCREASING USE OF SUSTAINED-RELEASE FORMULATIONS IN THE PHARMA INDUSTRY TO DRIVE MARKET GROWTH179
TABLE 171PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY REGION, 2020–2027 (USD MILLION)180
TABLE 172NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)180
TABLE 173EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS,
BY COUNTRY, 2020–2027 (USD MILLION)180
TABLE 174ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)181
7.5BINDERS181
7.5.1BINDERS PROVIDE FLUIDITY AND COMPRESSIBILITY ESSENTIAL FOR TABLET MANUFACTURING181
TABLE 175PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS, BY REGION,
2020–2027 (USD MILLION)182
TABLE 176NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS,
BY COUNTRY, 2020–2027 (USD MILLION)182
TABLE 177EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS,
BY COUNTRY, 2020–2027 (USD MILLION)182
TABLE 178ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS,
BY COUNTRY, 2020–2027 (USD MILLION)183
7.6FLAVORING AGENTS & SWEETENERS183
7.6.1FLAVORING AGENTS ARE USED TO IMPROVE THE PALATABILITY OF DRUGS183
TABLE 179PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY REGION, 2020–2027 (USD MILLION)183
TABLE 180NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2020–2027 (USD MILLION)184
TABLE 181EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2020–2027 (USD MILLION)184
TABLE 182ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2020–2027 (USD MILLION)184
7.7DISINTEGRANTS185
7.7.1DISINTEGRANTS CAUSE A RAPID BREAK-UP OF SOLID DOSAGE FORMS185
TABLE 183PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY REGION, 2020–2027 (USD MILLION)185
TABLE 184NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY COUNTRY, 2020–2027 (USD MILLION)185
TABLE 185EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS,
BY COUNTRY, 2020–2027 (USD MILLION)186
TABLE 186ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY COUNTRY, 2020–2027 (USD MILLION)186
7.8COLORANTS186
7.8.1COLORING AGENTS ARE USED IN HARD AND SOFT GELATIN CAPSULES, TABLETS, ORAL LIQUIDS, AND TOPICAL CREAMS186
TABLE 187PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS, BY REGION, 2020–2027 (USD MILLION)187
TABLE 188NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS, BY COUNTRY, 2020–2027 (USD MILLION)187
TABLE 189EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS,
BY COUNTRY, 2020–2027 (USD MILLION)187
TABLE 190ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS,
BY COUNTRY, 2020–2027 (USD MILLION)188
7.9LUBRICANTS & GLIDANTS188
7.9.1GLIDANTS IMPROVE THE FLOW PROPERTIES OF A FORMULATION BY REDUCING INTER-PARTICLE FRICTION AND COHESION188
TABLE 191PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS,
BY REGION, 2020–2027 (USD MILLION)188
TABLE 192NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY COUNTRY, 2020–2027 (USD MILLION)189
TABLE 193EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY COUNTRY, 2020–2027 (USD MILLION)189
TABLE 194ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY COUNTRY, 2020–2027 (USD MILLION)189
7.10PRESERVATIVES190
7.10.1BENZYL ALCOHOL IS A WIDELY USED PRESERVATIVE IN THE PHARMACEUTICAL AND NUTRACEUTICAL INDUSTRY190
TABLE 195PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES, BY REGION, 2020–2027 (USD MILLION)190
TABLE 196NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES, BY COUNTRY, 2020–2027 (USD MILLION)190
TABLE 197EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES,
BY COUNTRY, 2020–2027 (USD MILLION)191
TABLE 198ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES, BY COUNTRY, 2020–2027 (USD MILLION)191
7.11EMULSIFYING AGENTS191
7.11.1USE OF SOLUBILITY ENHANCEMENT EXCIPIENTS IN LIQUID DRUG FORMULATIONS HELPS INCREASE API BIOAVAILABILITY191
TABLE 199PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY REGION, 2020–2027 (USD MILLION)192
TABLE 200NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)192
TABLE 201EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)192
TABLE 202ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)193
7.12OTHER FUNCTIONALITIES193
TABLE 203PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES,
BY REGION, 2020–2027 (USD MILLION)193
TABLE 204NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2020–2027 (USD MILLION)193
TABLE 205EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2020–2027 (USD MILLION)194
TABLE 206ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2020–2027 (USD MILLION)194
8PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION195
8.1INTRODUCTION196
TABLE 207PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2020–2027 (USD MILLION)196
8.2ORAL FORMULATIONS196
TABLE 208PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,
BY REGION, 2020–2027 (USD MILLION)197
TABLE 209NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2020–2027 (USD MILLION)197
TABLE 210EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2020–2027 (USD MILLION)197
TABLE 211ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2020–2027 (USD MILLION)198
TABLE 212PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2020–2027 (USD MILLION)198

8.2.1TABLETS198
8.2.1.1Tablets are the most widely used dosage forms198
TABLE 213TYPICAL COMPOSITION OF TABLETS199
TABLE 214PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS, BY REGION,
2020–2027 (USD MILLION)199
TABLE 215NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS,
BY COUNTRY, 2020–2027 (USD MILLION)199
TABLE 216EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS,
BY COUNTRY, 2020–2027 (USD MILLION)200
TABLE 217ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS,
BY COUNTRY, 2020–2027 (USD MILLION)200
8.2.2CAPSULES200
TABLE 218PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY REGION,
2020–2027 (USD MILLION)201
TABLE 219NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY COUNTRY, 2020–2027 (USD MILLION)201
TABLE 220EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES,
BY COUNTRY, 2020–2027 (USD

Report Title: Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) - Global Forecast to 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW